ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,204Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 1111

$734K Total Retail Price of All Prescriptions

Rank: 97 out of 1111

298 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 9,674 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 442 372 1 5
LISINOPRIL 411 307 2 2
LEVOTHYROXINE SODIUM 410 357 3 3
METFORMIN HCL 380 314 4 8
HYDROCODONE-ACETAMINOPHEN 377 235 S3 5 1
OMEPRAZOLE 352 309 6 4
FUROSEMIDE 328 260 7 6
AMLODIPINE BESYLATE 247 229 8 7
POTASSIUM CHLORIDE 211 162 9 9
GABAPENTIN 196 159 10 10
TRAMADOL HCL 161 130 11 13
ALENDRONATE SODIUM 157 141 12 35
SERTRALINE HCL 156 147 13 24
METOPROLOL SUCCINATE 149 107 14 20
ROPINIROLE HCL 144 134 15 68
FLUTICASONE PROPIONATE 138 110 16 27
ZOLPIDEM TARTRATE 136 108 17 16
DONEPEZIL HCL 136 130 17 25
CRESTOR 134 104 19 33
HYDROCHLOROTHIAZIDE 125 105 20 11
NAMENDA 124 124 21 31
METOPROLOL TARTRATE 121 108 22 12
LYRICA 119 92 23 62
PRAVASTATIN SODIUM 117 99 24 17
CARVEDILOL 114 101 25 21
MELOXICAM 112 89 26 18
SPIRIVA 109 64 27 53
NEXIUM 106 62 28 26
ATORVASTATIN CALCIUM 104 79 29 15
WARFARIN SODIUM 103 101 30 19
CIPROFLOXACIN HCL 100 93 31 58
ALLOPURINOL 99 69 32 36
GLIPIZIDE 96 84 33 57
DETROL LA 87 82 34 139
CYMBALTA 87 69 34 40
ISOSORBIDE MONONITRATE ER 85 73 36 73
METHYLPREDNISOLONE 84 59 37 93
AZITHROMYCIN 82 61 38 39
PROAIR HFA 82 43 38 38
CYCLOBENZAPRINE HCL 78 40 R 40 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 73 41 23
CITALOPRAM HBR 74 56 42 14
DIOVAN HCT 73 46 43 94
MIRTAZAPINE 73 73 43 52
LOSARTAN POTASSIUM 73 71 43 34
TRAZODONE HCL 71 60 46 32
VENTOLIN HFA 71 58 46 122
CLONIDINE HCL 68 52 48 42
PREDNISONE 67 58 49 48
ATENOLOL 66 55 50 22
CELEBREX 65 54 51 81
ADVAIR DISKUS 63 48 52 43
LEVOFLOXACIN 63 56 52 88
CARISOPRODOL 61 0 R 54 54
DIOVAN 59 59 55 51
MEGESTROL ACETATE 59 59 R 55 103
PANTOPRAZOLE SODIUM 58 42 57 50
CEPHALEXIN 57 46 58 89
AMLODIPINE BESYLATE-BENAZEPRIL 55 49 59 67
CLOPIDOGREL 55 33 59 30
PAROXETINE HCL 53 26 61 55
ZETIA 53 41 61 109
JANUVIA 53 49 61 75
PREMARIN 53 30 R 61 90
AMOX TR-POTASSIUM CLAVULANATE 51 33 65 141
DIGOXIN 50 41 66 47
MORPHINE SULFATE ER 50 34 S2 66 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.